Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.
Eyenuk has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Eyenuk's investors include AXA Investment Managers, KOFA Healthcare, Kendall Capital Partners, Global Health Investment Fund (GHIF), T&W Medical.
Eyenuk is headquartered in Woodland Hills, United States.
Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance.
Eyenuk is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eyenuk — Funding & Investors." VCBacked, October 17, 2022, https://www.vcbacked.co/company/eyenuk. Accessed September 30, 2026.
VCBacked. (2022). Eyenuk — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/eyenuk
{{cite web |title=Eyenuk — Funding & Investors |url=https://www.vcbacked.co/company/eyenuk |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated